Is fever and diarrhea after receiving Vivotif (oral typhoid vaccine) normal, and how should it be managed?

Fever and Diarrhea After Vivotif Are Uncommon and Generally Mild

Fever and diarrhea after taking Vivotif (oral typhoid vaccine Ty21a) are not typical reactions and occur at very low rates, but when they do occur, they are generally mild and self-limited.

Expected Side Effects

According to FDA labeling, adverse reactions from oral typhoid vaccine (Vivotif) occur at a rate of less than 1 per 100,000 doses administered 1. The reactions specifically reported to the manufacturer consisted of:

• Nausea
• Abdominal cramps
• Vomiting
• Skin rash or urticaria

Notably, fever and diarrhea are NOT listed among the typical adverse reactions in the official FDA labeling 2.

Postmarketing Surveillance Data

A comprehensive review of the Vaccine Adverse Event Reporting System (VAERS) from 1990-2002 analyzed 345 reports for Ty21a vaccine 3. Key findings:

• Only 5.5% of reports described serious outcomes (death, hospitalization, permanent disability, or life-threatening illness)
• Gastroenteritis-like illness was recognized as an occasional event that sometimes required hospitalization
• The most frequently reported unexpected symptoms were fatigue and myalgia (not fever or diarrhea)
• The review concluded that VAERS reports "do not indicate any unexpected serious side effects"

Clinical Context and Management

When to Suspect Something Else

If fever and diarrhea occur after Vivotif, consider:

1. Timing matters: The vaccine contains live attenuated bacteria, but symptoms developing >24 hours after vaccination or persisting >24 hours should prompt evaluation for other causes 4

2. Alternative diagnoses:

   • Acute gastroenteritis from other pathogens
   • Food poisoning
   • Other travel-related infections
   • Medication interactions (see below)

Important Drug Interactions

Antibiotics and sulfonamides can interfere with vaccine efficacy and should not be taken during the vaccination course 2. The vaccine should also be postponed if persistent diarrhea or vomiting is already occurring 2.

Management Approach

For mild symptoms:

• Supportive care with oral rehydration is the mainstay 5
• Symptoms should be self-limited if truly vaccine-related
• Monitor for dehydration, especially in children

For concerning features requiring evaluation:

• Fever beginning >24 hours post-vaccination
• Fever persisting >24 hours
• Severe dehydration
• Bloody diarrhea
• Signs of systemic illness

Critical Pitfalls to Avoid

1. Don't assume all post-vaccination symptoms are vaccine-related: The extremely low rate of adverse events (<1/100,000) means other causes are statistically more likely 1

2. Don't give antimotility agents to children: Loperamide should not be given to anyone <18 years with acute diarrhea 5

3. Don't overlook incomplete vaccination: If symptoms interrupt the 4-dose schedule, optimal immune response may not be achieved 2, 6

4. Don't forget storage requirements: Vaccine must be refrigerated between doses; improper storage can affect both safety and efficacy 2, 6

Comparison to Injectable Vaccine

For context, the injectable (Vi polysaccharide) typhoid vaccine causes fever in only 1.1% of recipients, while the older whole-cell injectable vaccine caused fever in 15.7% 7. The oral Ty21a vaccine's rate of 2.0% for fever falls between these 7, though official FDA data suggests even lower rates.

Bottom line: True vaccine-related fever and diarrhea from Vivotif are rare. When present, they should be mild and self-limited. More severe or prolonged symptoms warrant evaluation for alternative diagnoses rather than attribution to the vaccine.